VUMC Launches Precision Medicine Subsidiary, Nashville Biosciences | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

VUMC Launches Precision Medicine Subsidiary, Nashville Biosciences

April 5, 2018
by Heather Landi
| Reprints
Click To View Gallery

Officials with Nashville-based Vanderbilt University Medical Center (VUMC) have launched a subsidiary to house the organization’s genomic and bioinformatics resources to advance drug and diagnostics discovery and development.

The subsidiary, Nashville Biosciences, will serve as a commercial interface between outside companies and the research resources housed in VUMC, including its comprehensive databank BioVU, which contains more than 250,000 DNA samples collected over the last decade, coupled with 2.8 million de-identified patient records.

According to VUMC officials, pharmaceutical and other life science companies can leverage the wealth of data contained within the Medical Center’s genomics and health information technology resources to accelerate their discovery and development of new treatments for patients, while helping to support institutional research efforts.

“Partnering with the pharmaceutical and broader life sciences industry through Nashville Biosciences will enable VUMC to expand and support its mission of advancing translational and precision medicine,” Leeland Ekstrom, Ph.D., chief operating officer of Nashville Biosciences, said in a statement.

“The creation of Nashville Biosciences will dramatically accelerate our ability to work with pharmaceutical and other partners to advance human health by accelerating rational drug and diagnostics development and use,” Dan Roden, M.D., VUMC’s senior vice president for personalized medicine.

Among the capabilities that will distinguish the company are analytical methods developed for “mining” DNA datasets. For example, researchers led by Josh Denny, M.D., vice president of personalized medicine, have pioneered techniques such as PheWAS that can link specific genetic mutations to their key clinical characteristics (known as disease phenotypes).

Prior to the official launch of Nashville Biosciences, VUMC has been working with a number of leading pharmaceutical and diagnostics companies to leverage these resources, including: Celgene Corporation, a biopharmaceutical company based in Summit, New Jersey; Pfizer Inc., a biopharmaceutical company based in New York, New York; Goldfinch Bio Inc., a biotechnology company based in Cambridge, Massachusetts focused on precision medicines for patients with kidney diseases; and Population Bio, Inc., a biotechnology company based in Melville, New York.

These projects, each of which aims to discover new treatments for patients in disease areas of interest for each partner, as well as multiple other ongoing efforts, will transition to the new company in the coming weeks, VUMC officials said.

“We’ve only just started to scratch the surface of what is possible with genomics and informatics resources that can be coalesced for research in a comprehensive academic medical center,” Gordon Bernard, M.D., executive vice president for research for VUMC.

“Partnering with Nashville Biosciences will greatly expand the national and global reach of these resources,” Bernard said.

2018 Nashville Health IT Summit

Renowned leaders in U.S. and North American healthcare gather throughout the year to present important information and share insights at the Healthcare Informatics Health IT Summits.

June 28 - 29, 2018 | Nashville

Topics

News

Report: Advanced Hacker Group, Orangeworm, Targeting Healthcare Industry

A new attack group, dubbed Orangeworm, is conducting targeted cyber attacks against healthcare organizations in the United States, Europe and Asia, according to a new report from researchers at cybersecurity firm Symantec.

EHR Capabilities Impact Patient Satisfaction Levels, Report Finds

Electronic health record (EHR) technology and the ways that providers use it to communicate with their colleagues and with patients is affecting how satisfied consumers are with their hospital organizations, according to a new Black Book market research.

A New Massachusetts Study Finds Consumers Slow to Make Use of Cost Estimate Tools

A new report has found that, even as health insurers in Massachusetts, under pressure to provide cost-estimating tools for their members, are giving them more information, plan members are still largely not taking advantage of new tools

Seven PA Health Systems Partnering on Healthy Food Access Pilot

Seven health systems in the Philadelphia are are partnering with community organizations, public health departments and insurers on a Healthy Food Access Pilot aimed at addressing food insecurity in the region.

Independence Health, Comcast to Partner on Healthcare Technology Platform

Independence Health Group, parent of Independence Blue Cross, and Comcast announced a partnership to launch a patient-centered technology and communications platform that seeks to improve the overall efficiency and experience of the care delivery process between providers and patients.

Health IT Trade Groups Push CMS for MIPS 90-Day Reporting Period

MGMA, AMA and 47 other physician organizations have sent a letter to CMS, calling for the federal agency to reduce the burden of the Merit-based Incentive Payment System (MIPS) by shortening the quality data reporting period from 365 to 90 days.